FirstAlerts

Accord Healthcare Recalls Levothyroxine Sodium Tablets, 88 mcg, Over Subpotency

The FDA's enforcement report lists a Class II recall of 1000-count prescription bottles distributed nationwide, with the firm's database showing no other enforcement action.

By AI ReporterWritten Sep 9, 2026, 9:33 p.m. ET
, of , North Carolina, is recalling Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg) in 1000-count bottles, according to the FDA's enforcement report for recall number . The report, dated September 2, 2026, lists the reason as and the classification as . The recall was initiated on August 6, 2026, and its status is . The affected lots are D2401813 and D2401814, with an expiration date of 08/31/2026, and D2500200 and D2500219, with an expiration date of 12/31/2026. The product is manufactured for , , NC 27617, and manufactured by Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, under NDC 16729-450-17. Distribution was . is the FDA's middle category, used where the product may cause temporary or medically reversible harm, and where the chance of serious harm is remote, according to the agency's recall definitions. The FDA's database records no other enforcement action by this firm. Levothyroxine Sodium Tablets, USP, are a finished oral pharmaceutical tablet made from synthetically produced levothyroxine sodium and solid inactive excipients, taken by mouth and distributed as a prescription-only drug product, according to the National Institutes of Health. They are normally sold as a prescription medication dispensed to consumers by licensed pharmacies from larger supply bottles.

Was this report accurate and useful?

Sources

Revision history

  1. Version 110 Sept 2026, 01:33current

    First published.

How we work

This site models an investigative reporter rather than a wire desk. The aim is the most complete, accurate and timely account we can assemble — all three, not a trade between them. Reports go out within minutes of the coverage they are built from, carrying context a newsroom would otherwise need a day and a records request to gather: what has happened at this place before, what the operator’s record is, which aircraft it actually was.

Reports are built from primary sources — accident and court records, official registries, weather observations, agency statements — and from reputable news organisations, each named where their reporting is used. Facts are extracted before anything is written, and every one must be supported by a quotation found in the source itself; the model that writes the report is given only those verified facts and never sees the article, so it cannot introduce a detail no source stated.

Where sources disagree we publish the disagreement, attributed, rather than picking a figure. Where a fact comes from a record rather than a reporter, we say so, and the language matches: an instrument reading is never described as something anyone confirmed. Some things are deliberately withheld — a suspect is not named until an agency names them on the record, victims until families or officials release them — and corrections appear as visible revisions, never as silent edits.

None of that makes a report true. A quotation check proves a source said something, not that it was right, and an automated system can be confidently wrong in ways the checks do not catch. If something here is wrong, the feedback above is how it gets found. The full methodology, including what we refuse to publish.